Natco Pharma

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue955.20654.801,0011,2771,344
Expenses531.20431.20568.20518.70547.10
EBITDA467.00267.80488.60802.80842.10
EBIT427.00227.40437.00762.40799.90
Profit Before Tax424.00223.60432.50758.00796.90
Net Profit360.20192.00349.10636.30661.10
Financial Ratios
Operating Profit Margin50.19%42.83%50.64%64.90%65.15%
Net Profit Margin38.71%30.71%36.18%51.44%51.14%
Earning Per Share (Diluted)20.1110.7219.4935.5336.91
Dividends Per Share0.001.251.253.001.50
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ